Your browser doesn't support javascript.
loading
Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report.
Haninger-Vacariu, Natalja; El-Hadi, Sarah; Pauler, Udo; Foretnik, Marina; Kain, Renate; Prohászka, Zoltán; Schmidt, Alice; Skuban, Nina; Barth, Jay A; Sunder-Plassmann, Gere.
Afiliação
  • Haninger-Vacariu N; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • El-Hadi S; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Pauler U; Department of Medicine I, University Hospital St. Pölten, Lower Austria, Austria.
  • Foretnik M; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Kain R; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Prohászka Z; Semmelweis University, Research Laboratory, Third Department of Internal Medicine, Budapest, Hungary.
  • Schmidt A; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Skuban N; Amicus Therapeutics, Inc., Cranbury, NJ, USA.
  • Barth JA; Amicus Therapeutics, Inc., Cranbury, NJ, USA.
  • Sunder-Plassmann G; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Case Rep Obstet Gynecol ; 2019: 1030259, 2019.
Article em En | MEDLINE | ID: mdl-31934472

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article